Skip to main content
Premium Trial:

Request an Annual Quote

New Products: MyCartis, Phenomenex, Waters

Premium

MyCartis this week launched its Evaluation multiplex biomarker analysis system.

The system is intended for simultaneous analysis of multiple protein and nucleic acid markers and features an integrated reaction and detection environment, the company said.


Phenomenex this week launched its Novum Simplified Liquid Extraction reagent for use in liquid-liquid extraction in cleanup of biological samples like plasma and urine.

According to the company, the reagent improves results while reducing instrument wear and tear compared to traditional reagents.


Waters this week released its Waters ACQUITY UPC2 Trefoil columns for chiral separations and its Waters ACQUITY UPC2 Torus columns for achiral separations. Both columns increase speed and selectivity while reducing method development time, the company said.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.